Strategies in the development of recombinant vaccines for colon cancer

Seminars in Oncology

Volumn 26, Issue 6, 1999, Pages 672-682

  Schlom, J ^a   Tsang, K Y ^a   Kantor, J A ^a   Abrams, S I ^a   Zaremba, S ^a   Greiner, J ^a   Hodge, J W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; GENE PRODUCT; ONCOFETAL ANTIGEN; VIRUS VECTOR;

ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOLOGY; CELL STIMULATION; COLON CANCER; HUMAN; IMMUNOMODULATION; MOLECULAR BIOLOGY; MOLECULAR CLONING; ONCOGENE; PRIORITY JOURNAL; SUPPRESSOR GENE; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; CLINICAL TRIALS; COLORECTAL NEOPLASMS; CYTOKINES; DRUG EVALUATION, PRECLINICAL; EPITOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; GENETIC VECTORS; HUMANS; LYMPHOCYTE ACTIVATION; POINT MUTATION; T-LYMPHOCYTES;

EID: 0033386109     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)